FDA Weighs Second Citizen Petition On Bamboo Health’s NarxCare

 
• By Mark McCarty
  
Two separate citizen petitions have asked the FDA to regulate Bamboo Health's NarxCare platform as CDS. (Zhanna Hapanovich/Shutterstock)

More from Digital Technologies

More from Medtech Insight